Takotsubo syndrome (TTS) is characterized by a transient left ventricular systolic dysfunction, burdened by significant acute and long-term mortality and morbidity. The prognosis of TTS, especially in the long-term, is influenced by both non-cardiovascular (non-CV) and CV comorbidities, among which cancer is one of the most common. The presence of a malignancy is proven to be associated with higher mortality in TTS. Moreover, a number of anticancer treatments has been reported to possibly cause TTS as a form of cardiotoxicity, even though clearcut associations are lacking. The aim of this narrative review is to sum up contemporary knowledge on the association of cancer and TTS, addressing unmet needs and practical implications. The importance of a close collaboration between cardiologists and oncologists is herein highlighted, both to allow an adequate management of the acute TTS phase, and to actively and safely return to the oncologic management once the acute setting is resolved.

A contemporary update on cancer and takotsubo syndrome / Tini, Giacomo; Arcari, Luca; Mistrulli, Raffaella; Follesa, Federico; Cianca, Alessandro; Sclafani, Matteo; Tocci, Giuliano; Spallarossa, Paolo; Battistoni, Allegra; Cacciotti, Luca; Musumeci, Beatrice; Barbato, Emanuele. - In: FRONTIERS IN CARDIOVASCULAR MEDICINE. - ISSN 2297-055X. - 10:(2024), pp. 1-7. [10.3389/fcvm.2023.1301383]

A contemporary update on cancer and takotsubo syndrome

Tini, Giacomo
;
Arcari, Luca;Mistrulli, Raffaella;Follesa, Federico;Cianca, Alessandro;Sclafani, Matteo;Tocci, Giuliano;Battistoni, Allegra;Musumeci, Beatrice;Barbato, Emanuele
2024

Abstract

Takotsubo syndrome (TTS) is characterized by a transient left ventricular systolic dysfunction, burdened by significant acute and long-term mortality and morbidity. The prognosis of TTS, especially in the long-term, is influenced by both non-cardiovascular (non-CV) and CV comorbidities, among which cancer is one of the most common. The presence of a malignancy is proven to be associated with higher mortality in TTS. Moreover, a number of anticancer treatments has been reported to possibly cause TTS as a form of cardiotoxicity, even though clearcut associations are lacking. The aim of this narrative review is to sum up contemporary knowledge on the association of cancer and TTS, addressing unmet needs and practical implications. The importance of a close collaboration between cardiologists and oncologists is herein highlighted, both to allow an adequate management of the acute TTS phase, and to actively and safely return to the oncologic management once the acute setting is resolved.
2024
cardio-oncology; anticancer treatments; cancer; cardiotoxicity; takotsubo syndrome
01 Pubblicazione su rivista::01a Articolo in rivista
A contemporary update on cancer and takotsubo syndrome / Tini, Giacomo; Arcari, Luca; Mistrulli, Raffaella; Follesa, Federico; Cianca, Alessandro; Sclafani, Matteo; Tocci, Giuliano; Spallarossa, Paolo; Battistoni, Allegra; Cacciotti, Luca; Musumeci, Beatrice; Barbato, Emanuele. - In: FRONTIERS IN CARDIOVASCULAR MEDICINE. - ISSN 2297-055X. - 10:(2024), pp. 1-7. [10.3389/fcvm.2023.1301383]
File allegati a questo prodotto
File Dimensione Formato  
Tini_contemporary-update_2024.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 248.51 kB
Formato Adobe PDF
248.51 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1700532
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact